Sonoma Pharmaceuticals
Financial ratios & Valuation

Forward Multiples (2026 – 2027)

20262027
Price/Earnings ratio
-58-40.15
Price/Sales ratio
0.760.73
Earnings per Share (EPS)
$-0.09$-0.13

Historical Multiples (2015 – 2024)

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 TTM Median
Valuation Ratios
Price/Earnings ratio
-0.98-1.543.26-1.16-0.64-2.45-3.21-2.09-0.64-0.28-0.43-0.64
Price/Sales ratio
0.581.042.361.000.400.380.790.840.240.100.230.38
Price/Book Value ratio
0.671.541.411.080.720.832.761.220.410.220.530.83
Price/Cash Flow ratio
-1.21-1.79-3.70-1.33-0.65-1.57-4.39-2.50-0.53-0.57-0.58-0.65
Price/Free Cash Flow ratio
-1.18-1.72-3.53-1.31-0.64-1.50-4.16-2.42-0.51-0.57-0.56-0.64
Price/Earnings Growth ratio
0.000.05-0.010.000.010.02-0.190.120.030.00-0.160.02
Dividend Yield
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Profitability Indicator Ratios
Gross Profit Margin
52.60%47.79%44.19%43.88%46.81%44.00%35.20%31.62%33.73%37.25%29.53%44.00%
Operating Profit Margin
-48.06%-67.30%-101.16%-85.17%-59.34%-35.22%-18.51%-46.61%-34.43%-36.91%-51.60%-59.34%
Pretax Profit Margin
-59.21%-67.36%-100.87%-86.01%-59.77%-14.91%-20.94%-42.90%-39.05%-39.50%-55.95%-59.77%
Net Profit Margin
-59.21%-67.36%72.31%-86.01%-62.19%-15.55%-24.77%-40.27%-38.81%-37.96%-54.05%-62.19%
Effective Tax Rate
3.04%2.37%32.99%5.63%-4.03%-4.28%-18.27%6.12%0.63%3.89%3.40%-4.03%
Return on Assets
-54.51%-73.62%36.42%-74.60%-81.65%-20.23%-30.79%-26.98%-31.73%-32.80%-48.72%-81.65%
Return On Equity
-68.05%-100.21%43.27%-93.48%-112.47%-33.84%-86.05%-58.47%-64.57%-78.78%-92.85%-112.47%
Return on Capital Employed
-53.41%-99.02%-58.51%-88.98%-103.69%-68.80%-31.61%-45.19%-36.51%-42.65%-64.83%-103.69%
Liquidity Ratios
Current Ratio
3.733.626.884.983.472.543.18N/AN/AN/A2.852.54
Quick Ratio
3.193.166.214.102.532.092.562.362.942.641.252.09
Cash ratio
2.372.105.313.081.020.751.031.271.020.840.660.75
Days of Sales Outstanding
39.9636.4959.9933.6766.9776.5854.9769.5770.7383.0666.7776.58
Days of Inventory outstanding
77.9376.02113.26111.86123.3175.4576.50112.56118.60124.20117.54117.54
Operating Cycle
117.90112.51173.26145.54190.29152.03131.48182.13189.34207.26134.00152.03
Days of Payables Outstanding
51.8061.9764.0049.6645.3971.1553.4969.3634.9027.7253.7145.39
Cash Conversion Cycle
66.0950.53109.2595.87144.8980.8877.99112.77154.44179.5442.0380.88
Debt Ratios
Debt Ratio
0.000.000.000.010.020.030.140.040.040.030.600.02
Debt Equity Ratio
0.000.010.000.010.030.050.400.090.080.081.500.03
Long-term Debt to Capitalization
N/AN/A0.000.000.00N/A0.19N/AN/AN/A0.030.00
Total Debt to Capitalization
0.000.010.000.010.030.050.280.080.070.070.080.03
Interest Coverage Ratio
-2.21K-3.38K-4.32K-354.72-341.15-416.93-287.41N/AN/AN/A1.29K-341.15
Cash Flow to Debt Ratio
-76.94-76.71-48.61-47.47-35.08-9.54-1.57-5.25-8.95-4.60-10.50-35.08
Company Equity Multiplier
1.241.361.181.251.371.672.792.162.032.402.501.37
Cash Flow Ratios
Operating Cash Flow / Sales Ratio
-0.48-0.57-0.63-0.74-0.61-0.24-0.18-0.33-0.46-0.18-0.40-0.61
Free Cash Flow / Operating Cash Flow Ratio
1.021.031.041.011.001.041.051.031.041.001.021.00
Cash Flow Coverage Ratio
-76.94-76.71-48.61-47.47-35.08-9.54-1.57-5.25-8.95-4.60-10.50-35.08
Short Term Coverage Ratio
-76.94-76.71-66.39-54.08-36.38-9.54-4.04-5.25-8.95-4.60-18.5-36.38
Dividend Payout Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A